Companies to leverage proprietary IgM antibody technology platform to discover agonists against three oncology targets and three immunology/inflammation targets
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer
Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options
It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry
A staggering 65% of the TB cases in India are in the 15-45 age group
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
Subscribe To Our Newsletter & Stay Updated
